Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans.
The angiogenic inducer Cyr61 is an extracellular matrix-associated heparin-binding protein that can mediate cell adhesion, stimulate cell migration, and enhance growth factor-stimulated DNA synthesis in both fibroblasts and endothelial cells in culture. In vivo, Cyr61 induces neovascularization and promotes tumor growth. Cyr61 is a prototypic member of a highly conserved family of secreted proteins that includes connective tissue growth factor, nephroblastoma overexpressed, Elm-1/WISP-1, Cop-1/WISP-2, and WISP-3. Encoded by an immediate early gene, Cyr61 synthesis is induced by serum growth factors in cultured fibroblasts and in dermal fibroblasts during cutaneous wound healing. We previously demonstrated that Cyr61 mediates adhesion of vascular endothelial cells and activation-dependent adhesion of blood platelets through direct interaction with integrins alpha(V)beta(3) and alpha(IIb)beta(3), respectively. In this study, we show that the adhesion of primary human skin fibroblasts to Cyr61 is mediated through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans (HSPGs), which most likely serve as co-receptors. Either destruction of cell surface HSPGs or prior occupancy of the Cyr61 heparin-binding site completely blocked cell adhesion to Cyr61. A heparin-binding defective mutant of Cyr61 was unable to mediate fibroblast adhesion through integrin alpha(6)beta(1) but still mediated endothelial cell adhesion through integrin alpha(V)beta(3), indicating that endothelial cell adhesion through integrin alpha(V)beta(3) is independent of the heparin-binding activity of Cyr61. These results identify Cyr61 as a novel adhesive substrate for integrin alpha(6)beta(1) and provide the first demonstration of the requirement for HSPGs in integrin-mediated cell attachment. In addition, these findings suggest that Cyr61 might elicit disparate biological effects in different cell types through interaction with distinct integrin receptors.
Chen
N
N
Department of Molecular Genetics, University of Illinois at Chicago College of Medicine, Chicago, Illinois 60607-7170, USA.
Chen
C C
CC
Lau
L F
LF
D000818:Animals; D002448:Cell Adhesion / Q000502:physiology*; D002460:Cell Line; D002462:Cell Membrane / Q000502:physiology; D055515:Cysteine-Rich Protein 61; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005347:Fibroblasts / Q000166:cytology / Q000502:physiology*; D017781:Genes, Immediate-Early; D006025:Glycosaminoglycans / Q000502:physiology; D006133:Growth Substances / Q000235:genetics / Q000502:physiology*; D019812:Heparan Sulfate Proteoglycans / Q000502:physiology*; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics / Q000502:physiology*; D039121:Integrin alpha6beta1; D016023:Integrins / Q000502:physiology*; D036341:Intercellular Signaling Peptides and Proteins; D007700:Kinetics; D008297:Male; D051379:Mice; D016297:Mutagenesis, Site-Directed; D016133:Polymerase Chain Reaction; D017469:Receptors, Fibronectin / Q000502:physiology; D017474:Receptors, Laminin / Q000502:physiology; D019030:Receptors, Vitronectin / Q000502:physiology; D011994:Recombinant Proteins / Q000378:metabolism; D012867:Skin / Q000166:cytology*; D018411:Spodoptera; D014162:Transfection
C501848:CCN1 protein, human; C491850:CCN1 protein, mouse; D055515:Cysteine-Rich Protein 61; D016326:Extracellular Matrix Proteins; D006025:Glycosaminoglycans; D006133:Growth Substances; D019812:Heparan Sulfate Proteoglycans; D017874:Immediate-Early Proteins; D039121:Integrin alpha6beta1; D016023:Integrins; D036341:Intercellular Signaling Peptides and Proteins; D017469:Receptors, Fibronectin; D017474:Receptors, Laminin; D019030:Receptors, Vitronectin; D011994:Recombinant Proteins